Skip to main content
NVDA-2.37%AAPL+1.52%GOOGL-0.14%MSFT+0.05%AMZN+0.02%TSM-1.10%SPCX+3.00%AVGO-0.14%META-0.14%TSLA-0.38%SKHY-3.41%MU-4.64%BRK-B-0.21%LLY+0.23%JPM-0.66%AMD-3.07%WMT+0.18%V+0.04%XOM+0.55%ASMLa-1.66%JNJ-0.39%INTC-4.87%MA-0.29%0700.HK-1.94%ORCL-2.91%1398.HK+0.79%BAC-0.63%ABBV+0.44%CSCO-0.88%CVX-0.04%COST+0.20%LRCX-4.56%KO+1.10%CAT-1.54%AMAT-2.25%0005.HK-0.78%AP2d-1.55%UNH-0.45%DELL-3.44%HSBA.L-1.30%MS-0.79%PG-0.14%GE-0.25%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX+0.18%HD-1.17%GS-0.92%0939.HK+1.66%NZDJPY-2.58%AUDJPY-1.83%CHFJPY-1.56%NZDCAD-1.46%EURNZD+1.41%GBPNZD+1.36%USDJPY-1.32%NZDUSD-1.29%GBPJPY-1.23%EURJPY-1.21%CADJPY-1.14%NZDCHF-1.05%USDZAR+0.91%EURZAR+0.85%AUDNZD+0.77%GBPZAR+0.77%USDNOK+0.76%USDSEK+0.75%AUDCAD-0.73%EURNOK+0.69%EURSEK+0.68%AUDDKK-0.66%EURAUD+0.63%GBPAUD+0.59%CHFNOK+0.56%CHFSEK+0.55%AUDUSD-0.52%AUDSGD-0.52%USDTHB+0.48%USDMXN+0.44%GBPTRY+0.41%CADCHF+0.41%NZDSGD-0.36%EURCHF+0.34%NOKJPY-0.33%GBPHKD+0.32%GBPCHF+0.32%USDPLN+0.31%GBPMXN-0.28%AUDCHF-0.28%USDCHF+0.25%EURPLN+0.24%SGDJPY+0.22%USDSGD+0.21%USDCAD-0.17%USDILS+0.16%NZDMXN-0.15%EURSGD+0.14%PLNJPY+0.11%GBPCAD-0.11%USDTRY+0.11%EURUSD+0.10%GBPUSD+0.08%EURCZK-0.08%EURHKD-0.08%USDCNH+0.08%EURCAD-0.08%USDDKK+0.06%GBPSGD+0.05%USDCOP-0.04%EURGBP+0.04%EURCNH+0.03%AUDNOK+0.03%USDHKD+0.01%CHFSGD+0.01%EURDKK0.00%XPTUSD-5.33%UKOIL+5.05%USOIL+4.73%HG1-4.70%XAGUSD-4.69%GAGUSD-4.68%SUGAR+2.54%GAUUSD-0.96%XAUUSD-0.96%COTTON+0.72%COFFEE-0.69%XNGUSD+0.64%BTCUSD-1.69%ETHUSD-1.24%USDTUSD-0.03%XRPUSD-3.15%SOLUSD-2.10%TRXUSDT0.00%ZECUSDT-7.17%DOGEUSD-3.23%XMRUSDT-1.42%LINKUSD-1.94%XLMUSD-2.45%BCHUSDT-10.50%LTCUSD-2.25%UNIUSD-2.93%TONUSD+24.88%HBARUSDT-2.55%SUIUSD-4.12%TAOUSDT-6.03%AAVEUSD-3.38%DOTUSDT-3.52%ICPUSDT-1.55%ONDOUSDT-3.87%WLDUSDT-3.39%ARBUSDT-0.70%ATOMUSDT-5.46%JUPUSDT-4.25%INJUSDT-5.73%STXUSDT-4.53%FETUSDT-4.21%TIAUSDT-2.18%PYTHUSDT-1.56%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-2.97%WIFUSDT-5.87%OPUSDT-4.00%POLUSDT-6.02%IOTAUSDT-4.48%AXSUSDT-2.90%FARTCOINUSDT-4.36%EOSUSDT-1.67%DYDXUSDT-3.33%ORDIUSDT-1.82%GALAUSDT-4.78%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.37%AAPL+1.52%GOOGL-0.14%MSFT+0.05%AMZN+0.02%TSM-1.10%SPCX+3.00%AVGO-0.14%META-0.14%TSLA-0.38%SKHY-3.41%MU-4.64%BRK-B-0.21%LLY+0.23%JPM-0.66%AMD-3.07%WMT+0.18%V+0.04%XOM+0.55%ASMLa-1.66%JNJ-0.39%INTC-4.87%MA-0.29%0700.HK-1.94%ORCL-2.91%1398.HK+0.79%BAC-0.63%ABBV+0.44%CSCO-0.88%CVX-0.04%COST+0.20%LRCX-4.56%KO+1.10%CAT-1.54%AMAT-2.25%0005.HK-0.78%AP2d-1.55%UNH-0.45%DELL-3.44%HSBA.L-1.30%MS-0.79%PG-0.14%GE-0.25%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX+0.18%HD-1.17%GS-0.92%0939.HK+1.66%NZDJPY-2.58%AUDJPY-1.83%CHFJPY-1.56%NZDCAD-1.46%EURNZD+1.41%GBPNZD+1.36%USDJPY-1.32%NZDUSD-1.29%GBPJPY-1.23%EURJPY-1.21%CADJPY-1.14%NZDCHF-1.05%USDZAR+0.91%EURZAR+0.85%AUDNZD+0.77%GBPZAR+0.77%USDNOK+0.76%USDSEK+0.75%AUDCAD-0.73%EURNOK+0.69%EURSEK+0.68%AUDDKK-0.66%EURAUD+0.63%GBPAUD+0.59%CHFNOK+0.56%CHFSEK+0.55%AUDUSD-0.52%AUDSGD-0.52%USDTHB+0.48%USDMXN+0.44%GBPTRY+0.41%CADCHF+0.41%NZDSGD-0.36%EURCHF+0.34%NOKJPY-0.33%GBPHKD+0.32%GBPCHF+0.32%USDPLN+0.31%GBPMXN-0.28%AUDCHF-0.28%USDCHF+0.25%EURPLN+0.24%SGDJPY+0.22%USDSGD+0.21%USDCAD-0.17%USDILS+0.16%NZDMXN-0.15%EURSGD+0.14%PLNJPY+0.11%GBPCAD-0.11%USDTRY+0.11%EURUSD+0.10%GBPUSD+0.08%EURCZK-0.08%EURHKD-0.08%USDCNH+0.08%EURCAD-0.08%USDDKK+0.06%GBPSGD+0.05%USDCOP-0.04%EURGBP+0.04%EURCNH+0.03%AUDNOK+0.03%USDHKD+0.01%CHFSGD+0.01%EURDKK0.00%XPTUSD-5.33%UKOIL+5.05%USOIL+4.73%HG1-4.70%XAGUSD-4.69%GAGUSD-4.68%SUGAR+2.54%GAUUSD-0.96%XAUUSD-0.96%COTTON+0.72%COFFEE-0.69%XNGUSD+0.64%BTCUSD-1.69%ETHUSD-1.24%USDTUSD-0.03%XRPUSD-3.15%SOLUSD-2.10%TRXUSDT0.00%ZECUSDT-7.17%DOGEUSD-3.23%XMRUSDT-1.42%LINKUSD-1.94%XLMUSD-2.45%BCHUSDT-10.50%LTCUSD-2.25%UNIUSD-2.93%TONUSD+24.88%HBARUSDT-2.55%SUIUSD-4.12%TAOUSDT-6.03%AAVEUSD-3.38%DOTUSDT-3.52%ICPUSDT-1.55%ONDOUSDT-3.87%WLDUSDT-3.39%ARBUSDT-0.70%ATOMUSDT-5.46%JUPUSDT-4.25%INJUSDT-5.73%STXUSDT-4.53%FETUSDT-4.21%TIAUSDT-2.18%PYTHUSDT-1.56%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-2.97%WIFUSDT-5.87%OPUSDT-4.00%POLUSDT-6.02%IOTAUSDT-4.48%AXSUSDT-2.90%FARTCOINUSDT-4.36%EOSUSDT-1.67%DYDXUSDT-3.33%ORDIUSDT-1.82%GALAUSDT-4.78%NOTUSDT-2.97%RONINUSDT-2.64%
ET

Esperion Therapeutics, Inc. (ESPR)

NASDAQ • Healthcare

$3.18
+$0 (+0.0%)
Market open

Last close at July 14, 2026 at 20:00 UTC

Open$3.18
Previous Close$3.18
Day Range$3.18 - $3.18
Avg. Volume (3M)0
Market Cap$661.1M
52 Week Range
$1.8$4.18

Metrics Over Time

Where the Money Goes

Q1 2026
Revenueeverything earned$80.1M100%
Gross Profitminus cost of goods$45.5M57%

In plain terms: out of every $100 in revenue, Esperion Therapeutics, Inc. currently loses $31.

Fundamentals & Financials

Revenue (TTM)
$418.2M
Net Income (TTM)
-$7.4M
EPS (TTM)
-$0.024
ROA (TTM)
-1.6%
Current Ratio
1.53

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-77.8%Q4 2025-$0.16
-4.3%Q1 2026$0.22
-150.0%Q2 2026-$0.1

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Esperion Therapeutics, Inc.

Esperion Therapeutics, Inc. is a NASDAQ-listed healthcare biotechnology company focused on developing and commercializing medicines for people with elevated low-density lipoprotein cholesterol, or LDL-C. In FY2025, it generated $403.1 million in revenue from that business, centered on prescription lipid-lowering therapies and related partnerships.

Name
Esperion Therapeutics, Inc.
CEO
Sheldon L. Koenig
Website
www.esperion.com
Industry
Healthcare
Year Founded
2008
Employees
294

Today's Snapshot

AI-generated

ESPR opened flat at 3.18, in line with a flat sector.

vs S&P 500 Today

Outperforming Market

+0.65%

Updated: September 10, 2026 at 14:44 UTC

Technical Indicators

5 Buy2 Neutral1 Sell
At 3.18 the setup shows constructive internals: price is trading above short and medium moving averages and above key longer-term averages, ADX signals a strong trending environment and on-balance volume is firmly positive. Momentum measures are generally supportive with CCI in bullish territory and RSI comfortably above neutral, although some oscillators are extended. Volatility is low with a narrow ATR near 0.7%, which has accompanied steady upside. Classic pivot sits at the current level, reinforcing recent acceptance of this price. Technical takeaway: Strong Buy, supported by trend strength, positive moving-average alignment and robust volume.
All signals
  • EMA (5 indicators)$3.00 - $3.17
    Buy
  • RSI (14)64.48
    Neutral
  • Stochastic %K (14, 3, 3)88.89
    Sell
  • MACD Level (12, 26)0.03
    Neutral

Peers & Related Assets

PTCTPTC Therapeutics, Inc.
$67.57-1.8%
AGIOAgios Pharmaceuticals, Inc.
$34.63+3.2%
COLLCollegium Pharmaceutical, Inc.
$23.36-0.0%
EBSEmergent BioSolutions Inc.
$5.68-5.3%
HRTXHeron Therapeutics, Inc.
$0.33-4.9%
KPTIKaryopharm Therapeutics Inc.
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.